Učitavanje...
Effect of asymmetric dimethylarginine (ADMA) on heart failure development
Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide synthases that limits nitric oxide bioavailability and can increase production of NOS derived reactive oxidative species. Increased plasma ADMA is a one of the strongest predictors of mortality in patients who have had a m...
Spremljeno u:
| Izdano u: | Nitric Oxide |
|---|---|
| Glavni autori: | , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5017793/ https://ncbi.nlm.nih.gov/pubmed/26923818 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.niox.2016.02.006 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|